FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

Wedmont Private Capital lessened its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 21.5% in the fourth ...

Claro Advisors LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 59.7% during the fourth ...

As deadly fires continue to rage in Los Angeles, healthcare companies far and wide are stepping up to serve those affected.

Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...